ACADIA Pharmaceuticals, Inc. (ACAD)
21.40
-0.69
(-3.12%)
USD |
NASDAQ |
May 15, 16:00
21.31
-0.09
(-0.42%)
After-Hours: 20:00
ACADIA Pharmaceuticals EPS Diluted (Quarterly) : 0.0211 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Insmed, Inc. | -0.7591 |
| Madrigal Pharmaceuticals, Inc. | -3.251 |
| BioMarin Pharmaceutical, Inc. | 0.5431 |
| MannKind Corp. | -0.0539 |
| Regeneron Pharmaceuticals, Inc. | 6.752 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.637M |
| Revenue (Quarterly) | 268.06M |
| Total Expenses (Quarterly) | 264.42M |
| Enterprise Value | 2.864B |
| Gross Profit Margin (Quarterly) | 90.75% |
| Profit Margin (Quarterly) | 1.36% |
| Earnings Yield | 10.26% |
| Operating Earnings Yield | 2.21% |
| Normalized Earnings Yield | 10.26 |